Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-24

Clinical Trial Update: Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating nifedipine XL vs placebo for treating severe preeclampsia during labor induction has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine XL (nifedipine extended-release)

Snippet

Sponsor: Ohio State University | Conditions: Preeclampsia Severe | Phase 4 | Status: COMPLETED | Results posted: 2023-07-24